The Science
VOCs don't lie. Cancer leaves a molecular trail in every breath.
Exhale Science is built on over four decades of peer-reviewed research linking volatile organic compounds in exhaled breath to cancer metabolism. We've translated that science into a clinical diagnostic platform.
Scientific Foundation
Why breath? Why VOCs?
Every cell in the body produces volatile organic compounds as byproducts of metabolism. Cancerous and pre-cancerous cells have fundamentally altered metabolic activity — they produce a distinct VOC signature that is exhaled with every breath. This is not a new hypothesis. It is a well-established biological phenomenon, documented across hundreds of peer-reviewed studies spanning lung, colorectal, breast, gastric, and other cancers.
"Exhaled breath contains thousands of VOCs. A subset of these are reliable biomarkers of malignancy — detectable before symptoms appear, before imaging reveals a mass."
The Mechanism
How cancer changes what you exhale.
Altered Cancer Metabolism
Cancer cells undergo metabolic reprogramming — the Warburg effect and other pathways produce elevated levels of specific aldehydes, alkanes, ketones, and aromatic compounds not present at the same concentrations in healthy tissue.
Systemic VOC Release
These metabolic byproducts enter the bloodstream and are transported to the lungs, where they diffuse across the alveolar membrane and are exhaled in breath — making breath a real-time window into systemic metabolic activity.
Breath Sample Capture
Our proprietary collection device captures the exhaled breath matrix, preserving VOC integrity for downstream analysis. Collection takes under two minutes and requires no patient preparation.
High-Sensitivity VOC Analysis
Captured samples are analyzed using high-sensitivity analytical instrumentation to identify and quantify the VOC profile with parts-per-billion precision.
AI Biomarker Classification
Our machine learning models — trained on clinically validated datasets — classify the VOC profile against known cancer biomarker signatures, generating a diagnostic output for clinical review.
The Evidence
Decades of research. One clear signal.
The scientific literature on breath-based cancer diagnostics spans more than 40 years. Below is a representative selection of the peer-reviewed evidence underpinning our platform.
Pauling et al.
Proceedings of the National Academy of Sciences
First systematic characterization of VOCs in human breath, establishing the scientific basis for breath analysis as a diagnostic modality.
Gordon et al.
Clinical Chemistry
Identified elevated levels of specific alkanes and methylated alkanes in the breath of lung cancer patients compared to healthy controls, with sensitivity and specificity exceeding 70%.
Bajtarevic et al.
Journal of Breath Research
Demonstrated that a panel of isoprene, acetone, and other VOCs could distinguish lung cancer patients from healthy controls and COPD patients with high accuracy.
Altomare et al.
Journal of Breath Research
VOC analysis of exhaled breath identified colorectal cancer patients with 75% sensitivity and 76% specificity — comparable to established screening biomarkers.
Amal et al.
Gut
A 13-VOC signature in exhaled breath distinguished gastric cancer from benign gastric conditions with 89% accuracy in a multi-center clinical study.
Markar et al.
JAMA Surgery
Intraoperative breath analysis identified esophageal and gastric cancer with 85% sensitivity and 87% specificity, demonstrating real-time diagnostic potential.
Our Advantage
What makes Exhale Science different.
Proprietary VOC Panel
We have identified and validated a proprietary panel of VOC biomarkers with superior sensitivity and specificity for cancer detection — developed through our own clinical research program.
Multi-Cancer Detection
Unlike single-cancer biomarker tests, our platform is designed to detect VOC signatures across multiple cancer types from a single breath sample.
Pre-Cancer Detection
Our models are trained to identify pre-cancerous metabolic signatures — enabling intervention before malignancy is established.
AI-Augmented Interpretation
Our proprietary machine learning models continuously improve as clinical data accumulates, increasing diagnostic accuracy over time.
Interested in the research?
We welcome inquiries from clinicians, researchers, and institutions interested in our science, clinical validation program, or partnership opportunities.